Trial reportBMC psychiatry2019
Effects of Attentional Bias Modification on residual symptoms in depression: a randomized controlled trial.
Trial report in BMC psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure
An Emoji-based Attention Bias Modification Intervention for Depressive Symptom Severity in Young Adults
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- 5-HTTLPR does not moderate the effect of attention bias modification for depression: a randomized sham-controlled trial.Translational psychiatry · 2025Trial
- Effect of attention bias modification on depressive affect.Scientific reports · 2025Trial
- The effect of attentional bias modification on positive affect dynamics.Scientific reports · 2024Trial
- The effect of attention bias modification on depressive symptoms in a comorbid sample: a randomized controlled trial.Psychological medicine · 2023Trial
- Attentional bias modification is associated with fMRI response toward negative stimuli in individuals with residual depression: a randomized controlled trialJournal of psychiatry & neuroscience : JPN · 2020Trial
- Serotonin transporter polymorphism (5-HTTLPR) is associated with post-awakening cortisol measures in previous depression.Comprehensive psychoneuroendocrinology · 2026Article
- Theta rhythm-based attention switch training can alleviate the difficulty in disengaging from negative stimuli.iScience · 2026Article
- Article
- Theta Rhythm-Based Attention Switch Training Effectively Modified Negative Attentional Bias.CNS neuroscience & therapeutics · 2024Article
- The effect of ABM on attentional networks and stress-induced emotional reactivity in a mixed clinical sample with depression: A randomized sham-controlled trial.Neuroscience applied · 2024Article
- Familial risk for depression is associated with reduced P300 and late positive potential to affective stimuli and prolonged cardiac deceleration to unpleasant stimuli.Scientific reports · 2023Article
- A review of attentional bias modification trainings for depression.CNS neuroscience & therapeutics · 2023Review
- Associations between Optimism and Attentional Biases as Measured by Threat-Avoidance and Positive-Search Tasks.Healthcare (Basel, Switzerland) · 2023Article
- Preferences for seeking effort or reward information bias the willingness to work.Scientific reports · 2022Article
- Cognitive bias modification for adult's depression: A systematic review and meta-analysis.Frontiers in psychology · 2022Article
- Sustained Attention and Working Memory Predict the Number of Days on Health-Related Benefits in the Year Following Occupational Rehabilitation.Journal of occupational rehabilitation · 2021Article
- Acceptance and Commitment Therapy Preceded by Attention Bias Modification on Residual Symptoms in Depression: A 12-Month Follow-Up.Frontiers in psychology · 2019Article
- Occupational Rehabilitation Is Associated With Improvements in Cognitive Functioning.Frontiers in psychology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 2 countries.
Funding
Abstract
backgroundFollowing treatment, many depressed patients have significant residual symptoms. However, large randomised controlled trials (RCT) in this population are lacking. When Attention bias modification training (ABM) leads to more positive emotional biases, associated changes in clinical symptoms have been reported. A broader and more transparent picture of the true advantage of ABM based on larger and more stringent clinical trials have been requested. The current study evaluates the early effect of two weeks ABM training on blinded clinician-rated and self-reported residual symptoms, and whether changes towards more positive attentional biases (AB) would be associated with symptom reduction.
methodA total of 321 patients with a history of depression were included in a preregistered randomized controlled double-blinded trial. Patients were randomised to an emotional ABM paradigm over fourteen days or a closely matched control condition. Symptoms based on the Hamilton Rating Scale for Depression (HRSD) and Beck Depression Inventory II (BDI-II) were obtained at baseline and after ABM training.
resultsABM training led to significantly greater decrease in clinician-rated symptoms of depression as compared to the control condition. No differences between ABM and placebo were found for self-reported symptoms. ABM induced a change of AB towards relatively more positive stimuli for participants that also showed greater symptom reduction.
conclusionThe current study demonstrates that ABM produces early changes in blinded clinician-rated depressive symptoms and that changes in AB is linked to changes in symptoms. ABM may have practical potential in the treatment of residual depression.
trial registrationClinicalTrials.gov ID: NCT02658682 (retrospectively registered in January 2016).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.